Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pumosetrag in GERD patients
NCT01161602Phase 2Completed
- Sponsor
- Edusa Pharmaceuticals
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of pumosetrag in gastroesophageal reflux disease (GERD), sponsored by Edusa Pharmaceuticals. Status: completed.
02
Drugs
pumosetrag
03
Conditions
gastroesophageal reflux disease (GERD)
Beyond the preview
Go deeper on NCT01161602.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01161602.